Hyphens Pharma International Ltd
SGX:1J5
Gross Margin
Hyphens Pharma International Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| SG |
H
|
Hyphens Pharma International Ltd
SGX:1J5
|
94.2m SGD |
36%
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
699.1B USD |
82%
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
56%
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
373.4B USD |
68%
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
2T DKK |
84%
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
211.2B CHF |
74%
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
184.2B CHF |
76%
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
166.2B GBP |
82%
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
193.3B USD |
78%
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD |
68%
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
133.5B USD |
75%
|
Hyphens Pharma International Ltd
Glance View
Hyphens Pharma International Ltd. is an investment holding company, which engages in the provision of specialty pharmaceutical and consumer healthcare products. The firm's principal activities are those of an investment holding company and provision of management services. The firm's segments include specialty pharma principals, proprietary brands, and medical hypermart and digital. The specialty pharma principals segment is engaged in the business of marketing and selling a range of specialty pharmaceutical products with exclusivity in the relevant ASEAN countries. The proprietary brands segment is engaged in the business of developing, marketing and selling its own proprietary range of dermatological products and health supplement products. The medical hypermart and digital segment is a wholesaler of pharmaceuticals and medical supplies in Singapore, which the Company and its subsidiaries position itself as a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Hyphens Pharma International Ltd's most recent financial statements, the company has Gross Margin of 35.6%.
You don't have any saved screeners yet